Christopher Strouse

771 total citations
49 papers, 319 citations indexed

About

Christopher Strouse is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Christopher Strouse has authored 49 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 21 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Christopher Strouse's work include Multiple Myeloma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Christopher Strouse is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Christopher Strouse collaborates with scholars based in United States, Canada and Jordan. Christopher Strouse's co-authors include Wael Saber, Mary M. Horowitz, Ashutosh K. Mangalam, Narendranath Epperla, Jun Zhang, Grant Prentice, Paul G. Richardson, Bijan Nejadnik, Robin Hume and Marcelo C. Pasquini and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher Strouse

34 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Strouse United States	9	159	129	94	36	27	49	319
Katharina Lisenko Germany	13	128 0.8×	104 0.8×	77 0.8×	48 1.3×	15 0.6×	24	309
Gevorg Tamamyan Armenia	7	93 0.6×	200 1.6×	86 0.9×	28 0.8×	27 1.0×	49	402
Sung‐Soo Yoon South Korea	9	152 1.0×	120 0.9×	91 1.0×	34 0.9×	34 1.3×	54	272
Nicholas M. Fisher United States	7	279 1.8×	157 1.2×	165 1.8×	15 0.4×	24 0.9×	14	411
Esprit Ma United States	9	159 1.0×	82 0.6×	102 1.1×	43 1.2×	58 2.1×	44	274
Natalie Schub Germany	8	164 1.0×	56 0.4×	143 1.5×	26 0.7×	14 0.5×	21	292
Shaoyan Hu China	10	124 0.8×	176 1.4×	61 0.6×	11 0.3×	59 2.2×	77	325
Laura Todt United States	6	264 1.7×	123 1.0×	160 1.7×	17 0.5×	22 0.8×	8	432
Satyajit Kosuri United States	12	247 1.6×	128 1.0×	150 1.6×	35 1.0×	73 2.7×	47	420
M. Lamba United States	8	76 0.5×	71 0.6×	89 0.9×	44 1.2×	10 0.4×	17	356

Countries citing papers authored by Christopher Strouse

Since Specialization

Citations

This map shows the geographic impact of Christopher Strouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Strouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Strouse more than expected).

Fields of papers citing papers by Christopher Strouse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Strouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Strouse. The network helps show where Christopher Strouse may publish in the future.

Co-authorship network of co-authors of Christopher Strouse

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Strouse. A scholar is included among the top collaborators of Christopher Strouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Strouse. Christopher Strouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dholaria, Bhagirathbhai, Mehmet H. Kocoglu, Leyla Shune, et al.. (2025). A Phase 1 Study of P-BCMA-ALLO1, a Non-Viral, Allogeneic BCMA Directed CAR-T in Relapsed/Refractory Multiple Myeloma (RRMM): Results from Optimized Lymphodepletion Cohort (Arm C). Transplantation and Cellular Therapy. 31(2). S38–S38.

Atrash, Shebli, Abdullah Khan, Hira Shaikh, et al.. (2025). Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals. Cancers. 17(21). 3569–3569.

Lesokhin, Alexander M., Rubén Niesvizky, Bertrand Arnulf, et al.. (2025). Prolonged elranatamab treatment interruption in patients with relapsed or refractory multiple myeloma (RRMM) is feasible: A retrospective analysis from MagnetisMM-3. Blood. 146(Supplement 1). 2269–2269.

Shaikh, Hira, James A. Davis, Nausheen Ahmed, et al.. (2024). P-079 Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 24. S87–S88. 1 indexed citations

Shaikh, Hira, Christopher Strouse, James A. Davis, et al.. (2024). Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial. Blood. 144(Supplement 1). 2411.2–2411.2. 1 indexed citations

Mott, Sarah L., et al.. (2024). Clinical outcomes of patients receiving three versus four doses of methotrexate with concomitant antithymocyte globulin in match unrelated donor allogeneic stem cell transplant: A single‐center experience. SHILAP Revista de lepidopterología. 5(3). 578–583.

Tomasson, Michael H., et al.. (2024). Comparison of outcomes by race among a population-based matched sample of multiple myeloma patients. Cancer Causes & Control. 36(4). 433–442.

Ahmed, Nausheen, Abdullah Khan, Hira Shaikh, et al.. (2024). A Real-World Analysis of the Safety and Efficacy of BCMA-Directed CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment. Blood. 144(Supplement 1). 2009–2009.

Alderuccio, Juan Pablo, Isildinha M. Reis, Jean L. Koff, et al.. (2023). Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood. 141(15). 1888–1893. 6 indexed citations

10.

Dima, Danai, James A. Davis, Nausheen Ahmed, et al.. (2023). Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience. Transplantation and Cellular Therapy. 30(3). 308.e1–308.e13. 40 indexed citations

11.

Sharma, Akshay, Brent R. Logan, Noel Estrada‐Merly, et al.. (2023). Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers. Transplantation and Cellular Therapy. 29(8). 523–528. 2 indexed citations

12.

Strouse, Christopher, Melissa C. Larson, Shawna L. Ehlers, et al.. (2022). Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis. JCO Oncology Practice. 18(7). e1069–e1080. 2 indexed citations

13.

Khurana, Arushi, Raphael Mwangi, Stephen M. Ansell, et al.. (2021). Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era. Blood Cancer Journal. 11(7). 133–133. 6 indexed citations

14.

Wang, Zhaoming, Michael S. Chimenti, Christopher Strouse, & George J. Weiner. (2021). T cells, particularly activated CD4+ cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity. Cancer Immunology Immunotherapy. 71(2). 237–249. 14 indexed citations

15.

Khurana, Arushi, Raphael Mwangi, Stephen M. Ansell, et al.. (2020). Estimates and Timing of Therapy Initiation during the First Decade for Patients with Follicular Lymphoma Who Were Observed at Diagnosis. Blood. 136(Supplement 1). 7–8. 1 indexed citations

16.

Strouse, Christopher, Ying Zhang, Mei‐Jie Zhang, et al.. (2018). Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 24(10). 2072–2080. 47 indexed citations

17.

Strouse, Christopher, Ashutosh K. Mangalam, & Jun Zhang. (2018). Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy. Gut Microbes. 10(2). 109–112. 17 indexed citations

18.

Strouse, Christopher, Paul G. Richardson, Grant Prentice, et al.. (2016). Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation. 22(7). 1306–1312. 40 indexed citations

19.

Fisher, Joseph B., Jonathan Peterson, Michael Reimer, et al.. (2016). The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9. Leukemia. 31(3). 712–719. 46 indexed citations

20.

Dhakal, Binod, Christopher Strouse, Anita D’Souza, et al.. (2014). Plerixafor and Abbreviated-Course Granulocyte Colony–Stimulating Factor for Mobilizing Hematopoietic Progenitor Cells in Light Chain Amyloidosis. Biology of Blood and Marrow Transplantation. 20(12). 1926–1931. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact